Spots Global Cancer Trial Database for stage ib breast cancer
Every month we try and update this database with for stage ib breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | NCT01824836 | Estrogen Recept... Musculoskeletal... Progesterone Re... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | anastrozole questionnaire a... laboratory biom... pharmacogenomic... | 18 Years - | Eastern Cooperative Oncology Group | |
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | NCT00068601 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... | 18 Years - 49 Years | SWOG Cancer Research Network | |
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | NCT01800422 | Stage IA Breast... Stage IB Breast... Stage II Breast... | telapristone ac... placebo therapeutic con... laboratory biom... questionnaire a... | 18 Years - | Northwestern University | |
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer | NCT00416403 | Breast Cancer | fluvastatin sod... Breast Cancer S... | - | University of California, San Francisco | |
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | NCT00712140 | Breast Cancer | trastuzumab parenteral chem... | 18 Years - | National Cancer Institute (NCI) | |
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment | NCT01573442 | Arthralgia Breast Cancer Hot Flashes Musculoskeletal... Sexual Dysfunct... | testosterone placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | NCT00830635 | Breast Cancer Depression Long-term Effec... Prostate Cancer Psychosocial Ef... | educational int... informational i... internet-based ... questionnaire a... study of socioe... survey administ... psychosocial as... quality-of-life... | - | University of Colorado, Denver | |
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. | NCT05318274 | Ductal Breast C... Invasive Breast... Early-stage Bre... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... | Hypofractionate... | 18 Years - | Coordinación de Investigación en Salud, Mexico | |
Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors | NCT03039140 | Cancer Survivor Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A... | 30 Years - 75 Years | Ohio State University Comprehensive Cancer Center | |
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | NCT00902330 | Anxiety Disorde... Breast Cancer Depression Fatigue Pain Sleep Disorders | energy-based th... sham interventi... | 18 Years - | Virginia Commonwealth University | |
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy | NCT02023008 | Anxiety Disorde... Depression Ductal Breast C... Fatigue Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | yoga therapy internet-based ... questionnaire a... | 18 Years - | Wake Forest University Health Sciences | |
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32 | NCT01666171 | Breast Cancer | metformin hydro... clinical observ... diagnostic labo... imaging biomark... medical chart r... digital mammogr... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery | NCT01106898 | Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | cyclophosphamid... paclitaxel trastuzumab laboratory biom... | 20 Years - | University of Nebraska | |
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid | NCT01409811 | Estrogen Recept... Invasive Ductal... Progesterone Re... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | zoledronic acid laboratory biom... therapeutic con... | - | City of Hope Medical Center | |
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions | NCT00262899 | Breast Cancer Psychosocial Ef... | counseling inte... educational int... psychosocial as... | 18 Years - | Georgetown University | |
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | NCT00712140 | Breast Cancer | trastuzumab parenteral chem... | 18 Years - | National Cancer Institute (NCI) | |
Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer | NCT00689975 | Breast Cancer | behavioral diet... exercise interv... counseling inte... flow cytometry immunoenzyme te... laboratory biom... complementary o... standard follow... | - | National Cancer Institute (NCI) | |
Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | NCT00902330 | Anxiety Disorde... Breast Cancer Depression Fatigue Pain Sleep Disorders | energy-based th... sham interventi... | 18 Years - | Virginia Commonwealth University | |
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery | NCT01292083 | Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Triple-negative... | azacitidine laboratory biom... immunohistochem... polymerase chai... western blottin... nucleic acid se... therapeutic con... | 18 Years - | University of Southern California | |
Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | NCT00931450 | Breast Cancer | exemestane sunitinib malat... placebo | - | National Cancer Institute (NCI) | |
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer | NCT00416403 | Breast Cancer | fluvastatin sod... Breast Cancer S... | - | University of California, San Francisco | |
Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors | NCT00486525 | Breast Cancer Depression Fatigue Pain | Yoga Therapy | 21 Years - | Ohio State University Comprehensive Cancer Center | |
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | NCT00427245 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... adjuvant therap... fertility asses... neoadjuvant the... | - | National Cancer Institute (NCI) | |
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 | NCT01286233 | Breast Cancer Depression Fatigue Sleep Disorders | Metformin Placebo | 18 Years - 74 Years | NSABP Foundation Inc | |
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 | NCT00963417 | Breast Cancer Osteoporosis | laboratory biom... dual x-ray abso... | 18 Years - 120 Years | ETOP IBCSG Partners Foundation | |
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | NCT03345420 | Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | Hypofractionate... | 18 Years - | University of Utah | |
Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | NCT00824538 | Breast Cancer | sunitinib malat... flow cytometry immunohistochem... laboratory biom... | 18 Years - 120 Years | University of California, San Francisco | |
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | NCT02587663 | Ductal Breast C... Stage IA Breast... Stage IB Breast... Stage II Breast... | Contrast-enhanc... Mammography Therapeutic Con... Ultrasonography Ultrasonography Gadolinium | 18 Years - | University of Southern California | |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer | NCT00899301 | Breast Cancer | biologic sample... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) | NCT03025139 | Cancer Survivor Early-Stage Bre... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Laboratory Biom... Meditation Ther... Questionnaire A... | - 49 Years | Jonsson Comprehensive Cancer Center | |
CADY Study ICORG 08-01 | NCT00968682 | Breast Cancer Cardiac Toxicit... | trastuzumab laboratory biom... assessment of t... | 18 Years - | Cancer Trials Ireland | |
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer | NCT02400060 | Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage 0 Breast ... | Telephone-Based... Survey Administ... Laboratory Biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831 | NCT00898898 | Breast Cancer | diagnostic labo... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | NCT01556243 | Breast Cancer | therapeutic con... whole breast ir... | 40 Years - | Alliance for Clinical Trials in Oncology | |
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer | NCT00062400 | Breast Cancer Psychosocial Ef... Sexual Dysfunct... Sexuality and R... | psychosocial as... | - 35 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin | NCT02677389 | Cancer Survivor Healthy Subject Stage I Colorec... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIA Color... Stage IIB Breas... Stage IIB Color... Stage IIC Color... Stage IIIA Brea... Stage IIIA Colo... Stage IIIB Brea... Stage IIIB Colo... Stage IIIC Brea... Stage IIIC Colo... | Educational Int... Internet-Based ... Monitoring Devi... Quality-of-Life... Questionnaire A... | 30 Years - 75 Years | University of Wisconsin, Madison | |
Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters | NCT00445562 | Breast Cancer | biologic sample... informational i... | 18 Years - | National Cancer Institute (NCI) | |
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors | NCT02235051 | Cancer Survivor Estrogen Recept... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Postmenopausal | exercise interv... laboratory biom... questionnaire a... quality-of-life... | 56 Years - | City of Hope Medical Center | |
Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer | NCT00818051 | Breast Cancer | intensity-modul... | 18 Years - | National Cancer Institute (NCI) | |
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery | NCT00450879 | Male Breast Car... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... | Pazopanib Hydro... Dynamic Contras... Pharmacological... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters | NCT00445562 | Breast Cancer | biologic sample... informational i... | 18 Years - | National Cancer Institute (NCI) | |
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors | NCT03284346 | Cancer Survivor No Evidence of ... Obesity Overweight Prostate Carcin... Sedentary Lifes... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Exercise Interv... Exercise Interv... Laboratory Biom... Monitoring Devi... Quality-of-Life... Questionnaire A... | 18 Years - | University of Southern California | |
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery | NCT01349322 | Breast Cancer | Standard fracti... Hypofractionate... Concurrent boos... Sequential boos... | 18 Years - | Radiation Therapy Oncology Group | |
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | NCT00872625 | Breast Cancer | cyclophosphamid... docetaxel epirubicin hydr... fluorouracil neoadjuvant the... therapeutic con... hypofractionate... image-guided ra... radiation thera... stereotactic ra... | 18 Years - | Centre Antoine Lacassagne | |
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | NCT01556243 | Breast Cancer | therapeutic con... whole breast ir... | 40 Years - | Alliance for Clinical Trials in Oncology | |
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) | NCT03025139 | Cancer Survivor Early-Stage Bre... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Educational Int... Laboratory Biom... Meditation Ther... Questionnaire A... | - 49 Years | Jonsson Comprehensive Cancer Center | |
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment | NCT02702830 | Healthy Subject Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Cardiopulmonary... Magnetic Resona... | 40 Years - 65 Years | Wake Forest University Health Sciences | |
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer | NCT00068328 | Breast Cancer Psychosocial Ef... | psychosocial as... quality-of-life... | 65 Years - | Alliance for Clinical Trials in Oncology | |
Window of Opportunity Study Targeting the Inflammatory Milieu | NCT01881048 | Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Omega-3 fatty a... Celecoxib | 18 Years - 50 Years | University of Colorado, Denver | |
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313 | NCT00949013 | Breast Cancer | immunohistochem... laboratory biom... | 18 Years - | SWOG Cancer Research Network | |
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer | NCT03345420 | Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... | Hypofractionate... | 18 Years - | University of Utah | |
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | NCT00066703 | Breast Cancer | exemestane tamoxifen triptorelin | 18 Years - 65 Years | ETOP IBCSG Partners Foundation | |
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel | NCT01243541 | Chemotherapeuti... Pain Peripheral Neur... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Therapy-related... | cryotherapy questionnaire a... quality-of-life... management of t... assessment of t... | 18 Years - | Northwestern University | |
High-Intensity Interval Training for Stage I-III Breast Cancer Patients | NCT02454777 | Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A... | 18 Years - | University of Southern California | |
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer | NCT00003854 | Breast Cancer | immunohistochem... lymphangiograph... sentinel lymph ... therapeutic con... whole breast ir... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. | NCT01276054 | Lymphedema Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... | technetium Tc 9... methylene blue indocyanine gre... sentinel lymph ... axillary lymph ... bioimpedance sp... quality-of-life... lymphedema mana... | 18 Years - | University of Southern California | |
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313 | NCT00896727 | Breast Cancer | gene expression... protein express... fluorescent ant... laboratory biom... | 18 Years - | SWOG Cancer Research Network | |
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer | NCT00893061 | Breast Cancer | anastrozole exemestane letrozole tamoxifen citra... | - 70 Years | National Cancer Institute (NCI) | |
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer | NCT03139435 | Peripheral Neur... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Biopsy Questionnaire A... Ultrasound Tomo... | - | Wake Forest University Health Sciences | |
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction | NCT02927912 | Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | Electron Beam T... Lumpectomy Quality-of-Life... Questionnaire A... Radiation Thera... Reconstructive ... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer | NCT01791998 | Ductal Breast C... Invasive Ductal... Stage IA Breast... Stage IB Breast... | magnetic resona... laser interstit... | - | University of Chicago | |
Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | NCT00471601 | Breast Cancer | counseling inte... questionnaire a... psychosocial as... quality-of-life... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
Phase I: At-Home Support for Rural Women Using Group Video Calling | NCT01672684 | Depression Post-traumatic ... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | support group t... educational int... | 21 Years - | Stanford University | |
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer | NCT01805076 | Estrogen Recept... Progesterone Re... Stage IA Breast... Stage IB Breast... Stage II Breast... Triple-negative... | Breast surgery Magnetic resona... Mammography | 18 Years - | Alliance for Clinical Trials in Oncology | |
Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | NCT01800422 | Stage IA Breast... Stage IB Breast... Stage II Breast... | telapristone ac... placebo therapeutic con... laboratory biom... questionnaire a... | 18 Years - | Northwestern University |